These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
215 related items for PubMed ID: 7672665
1. Plasma and hepatic carnitine and coenzyme A pools in a patient with fatal, valproate induced hepatotoxicity. Krähenbühl S, Mang G, Kupferschmidt H, Meier PJ, Krause M. Gut; 1995 Jul; 37(1):140-3. PubMed ID: 7672665 [Abstract] [Full Text] [Related]
2. Relationship between acid-soluble carnitine and coenzyme A pools in vivo. Brass EP, Hoppel CL. Biochem J; 1980 Sep 15; 190(3):495-504. PubMed ID: 7470064 [Abstract] [Full Text] [Related]
3. Relationship between the coenzyme A and the carnitine pools in human skeletal muscle at rest and after exhaustive exercise under normoxic and acutely hypoxic conditions. Friolet R, Hoppeler H, Krähenbühl S. J Clin Invest; 1994 Oct 15; 94(4):1490-5. PubMed ID: 7929825 [Abstract] [Full Text] [Related]
4. A single therapeutic dose of valproate affects liver carbohydrate, fat, adenylate, amino acid, coenzyme A, and carnitine metabolism in infant mice: possible clinical significance. Thurston JH, Carroll JE, Hauhart RE, Schiro JA. Life Sci; 1985 Apr 29; 36(17):1643-51. PubMed ID: 3921791 [Abstract] [Full Text] [Related]
5. Effects of ciprofibrate and 2-[5-(4-chlorophenyl)pentyl]oxirane-2-carboxylate (POCA) on the distribution of carnitine and CoA and their acyl-esters and on enzyme activities in rats. Relation between hepatic carnitine concentration and carnitine acetyltransferase activity. Bhuiyan AK, Bartlett K, Sherratt HS, Agius L. Biochem J; 1988 Jul 15; 253(2):337-43. PubMed ID: 3178716 [Abstract] [Full Text] [Related]
6. Interaction of carnitine and propionate with pyruvate oxidation by hepatocytes from clofibrate-treated rats: importance of coenzyme A availability. Brass EP. J Nutr; 1992 Feb 15; 122(2):234-40. PubMed ID: 1732464 [Abstract] [Full Text] [Related]
7. Amelioration of adverse effects of valproic acid on ketogenesis and liver coenzyme A metabolism by cotreatment with pantothenate and carnitine in developing mice: possible clinical significance. Thurston JH, Hauhart RE. Pediatr Res; 1992 Apr 15; 31(4 Pt 1):419-23. PubMed ID: 1570210 [Abstract] [Full Text] [Related]
8. The effect of acute and prolonged ethanol treatment on the contents of coenzyme A, carnitine and their derivatives in rat liver. Kondrup J, Grunnet N. Biochem J; 1973 Mar 15; 132(3):373-9. PubMed ID: 4737499 [Abstract] [Full Text] [Related]
9. Quantitation of the effect of L-carnitine on the levels of acid-soluble short-chain acyl-CoA and CoASH in rat heart and liver mitochondria. Lysiak W, Lilly K, DiLisa F, Toth PP, Bieber LL. J Biol Chem; 1988 Jan 25; 263(3):1151-6. PubMed ID: 3335535 [Abstract] [Full Text] [Related]
19. Reversal of the adverse chronic effects of the unsaturated derivative of valproic acid--2-n-propyl-4-pentenoic acid--on ketogenesis and liver coenzyme A metabolism by a single injection of pantothenate, carnitine, and acetylcysteine in developing mice. Thurston JH, Hauhart RE. Pediatr Res; 1993 Jan 25; 33(1):72-6. PubMed ID: 8433865 [Abstract] [Full Text] [Related]
20. Tissue acylcarnitine and acyl-coenzyme A profiles in chronically hyperammonemic mice treated with sodium benzoate and supplementary L-carnitine. Michalak A, Qureshi IA. Biomed Pharmacother; 1995 Jan 25; 49(7-8):350-7. PubMed ID: 8562862 [Abstract] [Full Text] [Related] Page: [Next] [New Search]